This finding has been documented in about a half of breast cancers and a quarter of pancreatic adenocarcinomas, suggesting a potential autocrine loop of the KGF/KGFR axis in these tumor cells [21], [43], [44]. The gene discussed is FGFR2; the disease is pancreatic adenocarcinoma.